dbt Core
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
A side-by-side editorial comparison of Omni and TrialEmulation — release velocity, themes, recent moves, and the top alternatives to consider.
Omni ships weekly, and almost every week the headline item is an AI feature.
Omni publishes a dated weekly digest whose body is a single line listing that week's items, so each entry compresses several releases into a sentence. Across the window the pattern is unmistakable: AI-powered semantic model generation reaching general availability, AI Routines creatable from chat and deliverable to Slack, AI model suggestion endpoints, AI credit controls scoped to embed entity groups and individual users, AI Evals on Azure, and MCP surfaces appearing both in-app and as a searchDashboards tool. The most recent week breaks that streak — default filters on composite topics, stopping a running dashboard query, full-screen preview editing — the first digest in two months led by conventional BI work.
Target trial emulation held steady by dependency maintenance, not new methods.
TrialEmulation implements target trial emulation from observational data, using duckdb to handle the expanded per-period datasets that approach generates. Every release in the visible window is upkeep: two consecutive releases removing the archived parglm dependency, two fixing tests against testthat updates, and two tracking duckdb sampling changes. No methodological work appears in the feed since before February 2025.
Omni publishes a dated weekly digest whose body is a single line listing that week's items, so each entry compresses several releases into a sentence. Across the window the pattern is unmistakable: AI-powered semantic model generation reaching general availability, AI Routines creatable from chat and deliverable to Slack, AI model suggestion endpoints, AI credit controls scoped to embed entity groups and individual users, AI Evals on Azure, and MCP surfaces appearing both in-app and as a searchDashboards tool. The most recent week breaks that streak — default filters on composite topics, stopping a running dashboard query, full-screen preview editing — the first digest in two months led by conventional BI work.
Two things have been happening in parallel and they are related. Omni pushed AI into the modelling layer rather than only the query layer, which is what semantic model generation reaching GA signified, then built the commercial and access controls those features require — credit limits per user and per embed entity group arrived within weeks of the capabilities that consume them. The MCP work points at a third direction, exposing Omni's content to external agents rather than only serving its own chat. The latest week's return to filters and query controls suggests the AI surface has reached the point where the surrounding product has to catch up to it.
With searchDashboards already shipped as an MCP tool, more of Omni's catalog is the obvious next thing to expose that way, and credit controls should keep extending to cover newer AI surfaces. Whether the non-AI week is a pause or a genuine rebalancing is not something one digest can settle.
TrialEmulation implements target trial emulation from observational data, using duckdb to handle the expanded per-period datasets that approach generates. Every release in the visible window is upkeep: two consecutive releases removing the archived parglm dependency, two fixing tests against testthat updates, and two tracking duckdb sampling changes. No methodological work appears in the feed since before February 2025.
The package is being kept installable rather than extended. Its dependency surface, duckdb for storage, parglm for fitting, testthat for checks, generates most of the release traffic, and CRAN archiving parglm forced two separate releases three months apart to fully excise it. The version numbering, still in the 0.0.4.x range after years, suggests the maintainers do not consider the API settled enough to promote.
Further releases will most likely be triggered by upstream dependency changes; the entries give no signal on when methodological work resumes.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either Omni or TrialEmulation.
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.
Holistics keeps fencing in the AI layer it spent the summer building.
Dovetail spent July opening doors to other tools and August making its own rooms easier to enter.
The 0.0.x train stops at CRAN: tulpa's engine ships to the ecosystem it already anchors.
AgencyAI got skills three weeks ago; everything since has been making them routine.
See all Omni alternatives → · See all TrialEmulation alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Omni is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Omni is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top Omni alternatives in Analytics are ranked by recent ship velocity. Browse the "Omni alternatives" section above for the current picks, or visit /alternatives/omni for the full list with editorial commentary on each.
Top TrialEmulation alternatives in Analytics are ranked by recent ship velocity. Browse the "TrialEmulation alternatives" section above for the current picks, or visit /alternatives/trialemulation for the full list with editorial commentary on each.